3/26
05:49 am
bmrn
BioMarin Pharmaceutical (BMRN) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
BioMarin Pharmaceutical (BMRN) was upgraded by Truist Financial Corporation to "strong-buy".
3/20
02:28 pm
bmrn
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks [Yahoo! Finance]
Low
Report
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks [Yahoo! Finance]
3/18
08:39 pm
bmrn
How The BioMarin (BMRN) Story Is Shifting With Voxzogo Risks And The Amicus Deal [Yahoo! Finance]
Low
Report
How The BioMarin (BMRN) Story Is Shifting With Voxzogo Risks And The Amicus Deal [Yahoo! Finance]
3/17
09:03 am
bmrn
BioMarin discontinues dosing in certain Voxzogo trials after safety concern [Yahoo! Finance]
Low
Report
BioMarin discontinues dosing in certain Voxzogo trials after safety concern [Yahoo! Finance]
3/16
12:08 pm
bmrn
BioMarin Pharmaceutical (BMRN) had its "outperform" rating reaffirmed by Wolfe Research.
Low
Report
BioMarin Pharmaceutical (BMRN) had its "outperform" rating reaffirmed by Wolfe Research.
3/16
09:52 am
bmrn
BioMarin stops mid-stage trials of bone disorder treatment [Yahoo! Finance]
Low
Report
BioMarin stops mid-stage trials of bone disorder treatment [Yahoo! Finance]
3/13
11:01 pm
bmrn
BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ in Adolescents [Yahoo! Finance]
Medium
Report
BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ in Adolescents [Yahoo! Finance]
3/13
05:34 am
bmrn
BioMarin Pharmaceutical Highlights Growth Plan, VOXZOGO Milestones, and Amicus Deal at Conference [Yahoo! Finance]
Low
Report
BioMarin Pharmaceutical Highlights Growth Plan, VOXZOGO Milestones, and Amicus Deal at Conference [Yahoo! Finance]
3/12
11:07 am
bmrn
BioMarin Pharmaceutical (BMRN) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
BioMarin Pharmaceutical (BMRN) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/12
09:27 am
bmrn
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M
Medium
Report
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M
3/12
09:05 am
bmrn
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M
Low
Report
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M
3/12
08:21 am
bmrn
American College of Medical Genetics and Genomics (ACMG) Clinical Genetics Meeting: Genomics presents new research highlighting underdiagnosis of rare genetic disorders [Yahoo! Finance]
Low
Report
American College of Medical Genetics and Genomics (ACMG) Clinical Genetics Meeting: Genomics presents new research highlighting underdiagnosis of rare genetic disorders [Yahoo! Finance]
3/11
04:23 pm
bmrn
BioMarin Pharmaceutical Inc. (BMRN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
BioMarin Pharmaceutical Inc. (BMRN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/11
08:03 am
bmrn
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $97.00 to $85.00. They now have a "buy" rating on the stock.
Low
Report
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $97.00 to $85.00. They now have a "buy" rating on the stock.
3/9
04:42 pm
bmrn
Do Options Traders Know Something About BMRN Stock We Don't? [Yahoo! Finance]
Low
Report
Do Options Traders Know Something About BMRN Stock We Don't? [Yahoo! Finance]
3/9
10:16 am
bmrn
BioMarin Pharmaceutical Inc. (BMRN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
BioMarin Pharmaceutical Inc. (BMRN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/7
02:53 am
bmrn
BioMarin Pharmaceutical Details Strategy Refresh, Voxzogo Competition and 40% Margin Goal at TD Cowen Confab [Yahoo! Finance]
Low
Report
BioMarin Pharmaceutical Details Strategy Refresh, Voxzogo Competition and 40% Margin Goal at TD Cowen Confab [Yahoo! Finance]
3/4
12:45 pm
bmrn
BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Low
Report
BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/3
07:18 am
bmrn
BioMarin Pharmaceutical (BMRN) had its "overweight" rating reaffirmed by Barclays PLC.
Low
Report
BioMarin Pharmaceutical (BMRN) had its "overweight" rating reaffirmed by Barclays PLC.
3/2
12:11 pm
bmrn
BioMarin Pharmaceutical (BMRN) was given a new $105.00 price target by Loop Capital.
Low
Report
BioMarin Pharmaceutical (BMRN) was given a new $105.00 price target by Loop Capital.
3/1
07:02 pm
bmrn
A Look At BioMarin (BMRN) Valuation After Recent Share Price Rebound [Yahoo! Finance]
Low
Report
A Look At BioMarin (BMRN) Valuation After Recent Share Price Rebound [Yahoo! Finance]
3/1
05:41 pm
bmrn
Spruce Biosciences Touts MPS IIIB Data, Targets Q4 BLA Submission at Oppenheimer Conference [Yahoo! Finance]
Low
Report
Spruce Biosciences Touts MPS IIIB Data, Targets Q4 BLA Submission at Oppenheimer Conference [Yahoo! Finance]
3/1
04:34 am
bmrn
Canaccord Lifts PT on BioMarin Pharmaceutical (BMRN) to $104 From $98 – Here's Why [Yahoo! Finance]
Low
Report
Canaccord Lifts PT on BioMarin Pharmaceutical (BMRN) to $104 From $98 – Here's Why [Yahoo! Finance]
2/28
02:39 am
bmrn
Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here's Why [Yahoo! Finance]
Low
Report
Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here's Why [Yahoo! Finance]
2/27
08:22 pm
bmrn
U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) [Yahoo! Finance]
Low
Report
U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) [Yahoo! Finance]